According to Zhitong Finance App News, Dizhe Pharmaceutical (688192.SH) released its report for the third quarter of 2026. In the first three quarters, the company achieved revenue of 4.77 billion yuan, an increase of 713.50% over the previous year. Net profit attributable to shareholders of listed companies was 3,639 billion yuan, and net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 3,612 billion yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.